Co-Authors
This is a "connection" page, showing publications co-authored by David Walt and Tal Gilboa.
Connection Strength
1.891
-
Sequential Protein Capture in Multiplex Single Molecule Arrays: A Strategy for Eliminating Assay Cross-Reactivity. Adv Healthc Mater. 2021 02; 10(4):e2001111.
Score: 0.901
-
Ultrasensitive Measurement of Both SARS-CoV-2 RNA and Antibodies from Saliva. Anal Chem. 2021 04 06; 93(13):5365-5370.
Score: 0.234
-
Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin Chem. 2020 12 01; 66(12):1562-1572.
Score: 0.229
-
Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19. Nat Biomed Eng. 2020 12; 4(12):1180-1187.
Score: 0.226
-
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. J Appl Lab Med. 2021 11 01; 6(6):1561-1570.
Score: 0.061
-
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies. Blood Adv. 2021 08 24; 5(16):3062-3065.
Score: 0.060
-
Protective heterologous TÂ cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens. Med (N Y). 2021 Sep 10; 2(9):1050-1071.e7.
Score: 0.060
-
Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021 07 15; 131(14).
Score: 0.060
-
Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2. BMC Infect Dis. 2021 Jun 16; 21(1):580.
Score: 0.059